These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17524034)

  • 21. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
    Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
    Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
    Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
    Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
    Hegele RA; Cao H; Anderson CM; Hramiak IM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenomics and lamins: from disease to therapy.
    Hegele RA; Oshima J
    Exp Cell Res; 2007 Jun; 313(10):2134-43. PubMed ID: 17466974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
    Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
    Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
    Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
    Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
    Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
    Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
    Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
    Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-nucleotide polymorphisms of the nuclear lamina proteome.
    Hegele RA; Yuen J; Cao H
    J Hum Genet; 2001; 46(6):351-4. PubMed ID: 11393540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from human mutations in PPARgamma.
    Hegele RA
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LMNA gene mutation search in Polish patients: new features of the heterozygous Arg482Gln mutation phenotype.
    Klupa T; Szopa M; Skupien J; Wojtyczek K; Cyganek K; Kowalska I; Malecki MT
    Endocrine; 2009 Dec; 36(3):518-23. PubMed ID: 19859838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A.
    Andre P; Schneebeli S; Vigouroux C; Lascols O; Schaaf M; Chevalier P
    Am Heart J; 2015 Apr; 169(4):587-93. PubMed ID: 25819867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
    Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
    Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A complex case of diabetes due to LMNA mutation].
    Ambonville C; Bouldouyre MA; Laforêt P; Richard P; Benveniste O; Vigouroux C
    Rev Med Interne; 2017 Oct; 38(10):695-699. PubMed ID: 28545855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.
    Chirico V; Ferraù V; Loddo I; Briuglia S; Amorini M; Salpietro V; Lacquaniti A; Salpietro C; Arrigo T
    Diabetes Metab; 2014 Jun; 40(3):224-8. PubMed ID: 24485160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein.
    Rajendran V; Purohit R; Sethumadhavan R
    Amino Acids; 2012 Aug; 43(2):603-15. PubMed ID: 21989830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement.
    Carboni N; Porcu M; Mura M; Cocco E; Marrosu G; Maioli MA; Solla E; Tranquilli S; Orrù P; Marrosu MG
    Muscle Nerve; 2010 Jan; 41(1):85-91. PubMed ID: 19768759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD).
    Magracheva E; Kozlov S; Stewart CL; Wlodawer A; Zdanov A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):665-70. PubMed ID: 19574635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
    Verstraeten VL; Caputo S; van Steensel MA; Duband-Goulet I; Zinn-Justin S; Kamps M; Kuijpers HJ; Ostlund C; Worman HJ; Briedé JJ; Le Dour C; Marcelis CL; van Geel M; Steijlen PM; van den Wijngaard A; Ramaekers FC; Broers JL
    J Cell Mol Med; 2009 May; 13(5):959-71. PubMed ID: 19220582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
    Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.